Odyssey Health, Inc. (ODYY) Form 10-K Annual Reports
Odyssey Health, Inc. (ODYY) is a publicly traded company on the OTC, categorized under SIC 3841 (Surgical & Medical Instruments & Apparatus). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: ODYY
CIK: 1626644
Exchange: OTC
SIC 3841: Surgical & Medical Instruments & Apparatus
Fiscal Year End: 07/31
State: NV
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Turner, Stone & Company, L.L.P.
Auditor SinceSince 7/31/2020 12:00:00 AM
Lead Engagement PartnerJohn Bodden
Audit LocationDallas, Texas, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 8-K | 2026-10-05 | 2026-09-29 | CURRENT REPORT | 0001683168-26-007625 | View SEC Doc Filr Page |
| 10-Q | 2026-06-12 | 2026-04-30 | FORM 10-Q FOR APR 2026 | 0001683168-26-004820 | View SEC Doc Filr Page |
| 8-K | 2026-05-26 | 2025-09-18 | AMENDMENT #1 TO FORM 8-K | 0001683168-26-004280 | View SEC Doc Filr Page |
| 8-K | 2026-05-11 | 2026-05-06 | FORM 8-K | 0001683168-26-003682 | View SEC Doc Filr Page |
| 8-K | 2026-04-24 | 2026-04-21 | CURRENT REPORT | 0001683168-26-003205 | View SEC Doc Filr Page |
| 10-Q | 2026-03-12 | 2026-01-31 | FORM 10-Q FOR JAN 2026 | 0001683168-26-001695 | View SEC Doc Filr Page |
| 8-K | 2026-02-03 | 2026-01-30 | CURRENT REPORT | 0001683168-26-000730 | View SEC Doc Filr Page |
| EFFECT | 2025-12-30 | — | EFFECT Filing | 9999999995-25-003967 | View SEC Doc Filr Page |
| 424B3 | 2025-12-30 | — | FORM 424B3 | 0001683168-25-009405 | View SEC Doc Filr Page |
| CORRESP | 2025-12-23 | — | CORRESP Filing | 0001683168-25-009342 | View SEC Doc Filr Page |
| S-1 | 2025-12-19 | — | REGISTRATION STATEMENT | 0001683168-25-009284 | View SEC Doc Filr Page |
| 10-Q | 2025-12-11 | 2025-10-31 | FORM 10-Q FOR OCT 2025 | 0001683168-25-009080 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2025-11-21 | — | SCHEDULE 13G/A Filing | 0001683168-25-008621 | View SEC Doc Filr Page |
| 8-K | 2025-11-19 | 2025-11-13 | CURRENT REPORT | 0001683168-25-008530 | View SEC Doc Filr Page |
| 10-K | 2025-10-29 | 2025-07-31 | FORM 10-K FOR JULY 2025 | 0001683168-25-007842 | View SEC Doc Filr Page |
| 8-K | 2025-10-17 | 2025-10-14 | CURRENT REPORT | 0001683168-25-007644 | View SEC Doc Filr Page |
| 8-K | 2025-10-10 | 2025-10-09 | FORM 8-K | 0001683168-25-007502 | View SEC Doc Filr Page |
| 8-K | 2025-10-08 | 2025-10-03 | CURRENT REPORT | 0001683168-25-007462 | View SEC Doc Filr Page |
| 8-K | 2025-09-22 | 2025-09-18 | FORM 8-K | 0001683168-25-007178 | View SEC Doc Filr Page |
| 8-K | 2025-08-29 | 2025-08-27 | CURRENT REPORT | 0001683168-25-006584 | View SEC Doc Filr Page |
| EFFECT | 2025-08-20 | — | EFFECT Filing | 9999999995-25-002688 | View SEC Doc Filr Page |
| 424B3 | 2025-08-20 | — | PROSPECTUS | 0001683168-25-006334 | View SEC Doc Filr Page |
| 8-K | 2025-08-15 | 2025-08-14 | FORM 8-K | 0001683168-25-006257 | View SEC Doc Filr Page |
| S-1/A | 2025-08-15 | — | AMENDMENT NO 2 | 0001683168-25-006245 | View SEC Doc Filr Page |
| CORRESP | 2025-08-15 | — | CORRESP Filing | 0001683168-25-006238 | View SEC Doc Filr Page |